Sansum Diabetes Research Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1944-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.sansum.org
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Phase 2
Completed
- Conditions
- Diabetes During Pregnancy
- Interventions
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 17
- Registration Number
- NCT01662921
- Locations
- 🇺🇸
William Sansum Diabetes Center, Santa Barbara, California, United States
Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
Phase 4
Completed
- Conditions
- Gestational Diabetes Mellitus
- Interventions
- Drug: Insulin, Long-Acting and Insulin
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01613807
Controlled Insulin Delivery: Combining Technology With Treatment
Early Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 19
- Registration Number
- NCT01484457
- Locations
- 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States
🇮🇱Schneider Children's Medical Center of Israel, Petah Tikva, Israel
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)
Early Phase 1
Completed
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 12
- Registration Number
- NCT01472406
- Locations
- 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States
Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes
Phase 1
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- Drug: Estradiol, medroxyprogesterone, hydrocortisone, GHDrug: Matching placebo
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Sansum Diabetes Research Institute
- Registration Number
- NCT01265017
- Locations
- 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States